• Markets
    • icon
  • Companies
PBP · ASX

Probiotec Limited (ASX:PBP)

AU$2.45

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
HALO Ords GROWTH AUS EMA 125 Breakdown Consensus Cheap All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PBP Overview

PBP Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About PBP

Website

Probiotec Limited

Telephone

61.3.9278.7555

Address

Laverton North 83 Cherry Lane Melbourne, Victoria (VIC) 3026

Description

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. It operates through the following segments: Branded Pharmaceuticals, Contract Manufacturing, Obesity and Weight Management, Europe, and Specialty Products. The Branded Pharmaceuticals segment involves the sale of branded pharmaceutical products. The Contract Manufacturing segment involves the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies. The Obesity and Weight Management segment is involved in the manufacture and sale of a range of products across a number of channels including FMCG, pharmacy, health food stores and online. The Europe segment is involved in the manufacture and sale of products within Europe. The Specialty Products segment involves in the sale of human and animal nutrition products, incorporating the sale of ingredients and additives for use in the pharmaceutical and food industries. The company was founded in 1997 and is headquartered in Melbourne, Australia.

PBP Price Chart

Key Stats

Market Cap

AU$199.24M

PE

15.70

EV/EBITDA

7.0

Dividends Overview

DIV Yield

2.3%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.16 - 2.91

Trade Value (12mth)

AU$30,069.00

1 week

1.66%

1 month

2.08%

YTD

9.87%

1 year

8.89%

All time high

2.91

Key Fundamentals

EPS 3 yr Growth

172.600%

EBITDA Margin

16.20%

Operating Cashflow

$17m

Free Cash Flow Return

12.00%

ROIC

7.70%

Interest Coverage

6.00

Quick Ratio

0.60

Other Data

Shares on Issue (Fully Dilluted)

84m

HALO Sector

Healthcare

Next Company Report Date

21-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PBP Announcements

Latest Announcements

Date Announcements

31 October 22

Change of Registry Address

×

Change of Registry Address

31 October 16

Annual Report to shareholders

×

Annual Report to shareholders

31 August 11

Investor Presentation

×

Investor Presentation

29 March 07

Citigroup Conference Presentation

×

Citigroup Conference Presentation

29 August 19

Investor Presentation - FY19 Results

×

Investor Presentation - FY19 Results

29 August 07

Investor Presentation

×

Investor Presentation

28 October 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 22

Annual Report to shareholders

×

Annual Report to shareholders

28 October 14

Annual Report to shareholders

×

Annual Report to shareholders

28 November 22

Major NSW Site Cosolidation

×

Major NSW Site Cosolidation

28 November 22

CEO ADDRESS AND TRADING UPDATE

×

CEO ADDRESS AND TRADING UPDATE

28 November 22

Chairmans Address to AGM

×

Chairmans Address to AGM

28 November 22

Results of Meeting

×

Results of Meeting

28 January 22

Director Appointment

×

Director Appointment

28 February 22

Share sale by CEO

×

Share sale by CEO

27 October 20

AGM Presentation

×

AGM Presentation

27 August 20

FY20 Results Presentation

×

FY20 Results Presentation

26 March 07

Upcoing Presentation

×

Upcoing Presentation

26 February 19

Investor Presentation - HY Results

×

Investor Presentation - HY Results

25 September 20

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

25 September 20

Annual Report to shareholders

×

Annual Report to shareholders

25 October 13

Annual Report to shareholders

×

Annual Report to shareholders

25 October 13

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

25 October 10

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

25 October 10

Annual Report to shareholders

×

Annual Report to shareholders

25 February 22

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

25 February 22

Dividend/Distribution - PBP

×

Dividend/Distribution - PBP

25 February 22

HY22 Investor Presentation and Outlook

×

HY22 Investor Presentation and Outlook

PBP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.06 0.17 0.14 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.06 0.17 0.13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.2 170.6 -20.8 Lock Lock Lock
     PE X Lock Lock Lock Lock 21.1 13.3 15.7 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 9.7 6.2 7.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.19 0.28 0.31 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.22 0.13 0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 121.0 42.2 11.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock 10.4 5.9 1.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.05 0.06 0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.1 10.0 18.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.5 2.8 2.3 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 79 32 48 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.87 0.97 1.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.20 -0.09 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -184.8 56.6 134.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 79 80 83 Lock Lock Lock
Basic m Lock Lock Lock Lock 77 80 81 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 121 182 214 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.4 51.3 17.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 25 35 41 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 32 55 62 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.1 68.7 12.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 27.0 30.1 28.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 73 70 71 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 16 32 35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.6 104.2 8.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 13.0 17.5 16.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 8 12 14 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 7 20 21 Lock Lock Lock
     Growth % Lock Lock Lock Lock -37.7 162.5 5.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.2 10.8 9.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 8 18 16 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 3 4 5 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 5 14 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.2 182.8 -19.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 4.0 7.5 5.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 24 20 17 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 4 7 10 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -36 -16 -14 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 34 -9 -12 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 21 15 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 162.0 -31.7 -35.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 2 8 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 28 22 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 231 238 235 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 90 84 35 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 69 71 74 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 162 159 148 Lock Lock Lock
Equity $m Lock Lock Lock Lock 69 79 87 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 158 163 122 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.5 3.1 -25.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 2.1 5.8 4.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.1 17.3 12.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 5.7 11.6 11.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.0 8.5 7.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 19.3 12.1 12.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 4.7 7.5 6.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 4.4 2.2 2.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 100.4 89.6 84.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.5 1.5 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.2 1.1 0.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 41.9 29.7 18.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 54.8 38.0 18.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.1 6.5 6.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 5.9 7.6 7.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 5.2 7.9 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.0 11.3 10.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.8 0.9 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.8 0.9 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.4 9.9 7.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 3.3 7.6 6.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 34.3 24.0 29.3 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 2.1 5.8 4.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 3.4 3.0 2.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.1 17.3 12.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 20.9 67.8 52.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 1.5 11.8 6.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 61.4 48.0 52.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 71.8 55.7 57.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 133.2 103.7 109.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 58.2 46.2 51.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 74.9 57.5 58.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

2.3%

Franking Level

100%

DPSg

18.18%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PBP Shortsell

Frequently Asked Questions

The current share price of Probiotec Limited (PBP:ASX) is AU$2.45.
The 52-week high share price for Probiotec Limited (PBP:ASX) is AU$2.91.
The 52-week low share price for Probiotec Limited (PBP:ASX)? is AU$2.16.
The current TTM dividend payout for Probiotec Limited (PBP:ASX) is 2.30.
The last dividend payment of Probiotec Limited (PBP:ASX) is AU$0.04.
Probiotec Limited (PBP:ASX) has a franking level of 100%.
Probiotec Limited (PBP:ASX) is classified in the Healthcare.
The current P/E ratio for Probiotec Limited (PBP:ASX) is 15.70.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.